MANE
MANE clinical trials: Veradermics, Inc
Every trial on ClinicalTrials.gov where Veradermics, Inc is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 5
- Trials linked
- 5
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
MANE on the catalyst calendar · MANE registry changes
- Primary completion Jun 2027Sponsor estimatePhase 3NCT07146022Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)Veradermics, Inc. · Androgenetic Alopecia (AGA)Active, not recruitingMANELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 3NCT06972264Safety and Efficacy of VDPHL01 in Males With AGAVeradermics, Inc. · Androgenetic AlopeciaActive, not recruitingMANELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2026Sponsor estimatePhase 2/Phase 3NCT06724614Efficacy and Safety of VDPHL01 in Males With AGAVeradermics, Inc. · Androgenetic AlopeciaActive, not recruitingMANELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2026Sponsor estimatePhase 2NCT06527365Safety and Efficacy of VDPHL01 in Males and Females With AGAVeradermics, Inc. · Androgenetic AlopeciaActive, not recruitingMANELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 25, 2025ActualPhase 2NCT05799157Safety and Efficacy of VDMN-21 Patch in Subjects With Common WartsVeradermics, Inc. · Verruca VulgarisCompletedMANELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 5 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner